Signal
The signal is not one single med spa law. It is the pattern. States are formalizing what many operators treated as gray area: cosmetic injections are medical procedures, lasers and energy devices are not casual spa equipment, prescription products require real prescribing and sourcing controls, IV add-ons trigger medical and pharmacy rules, and medical directors are expected to supervise more than a brand name.
The states are moving at different speeds, but the direction is consistent: med spas are being pulled into medical governance.
Why It Matters
Med spas are no longer hiding in a niche corner of aesthetics. The model has expanded into prescription weight-loss medication, IV therapy, peptide-adjacent offers, hormone support, regenerative add-ons, RF microneedling, lasers, and other medicalized services. That expansion increases revenue per patient, but it also increases the number of regulatory hooks.
A clinic may think it is simply adding services. Regulators may see the unauthorized practice of medicine, improper delegation, unsafe drug sourcing, inadequate patient assessment, misleading advertising, or failure to disclose provider credentials.
Blast Radius
This affects med spas, aesthetic clinics, laser clinics, wellness clinics, GLP-1 and weight-loss clinics, IV therapy clinics, dental spas, dermatology practices, plastic surgery-adjacent businesses, and MSO-backed aesthetic platforms.
The highest-risk operators are those using remote or passive medical directors, injector-led workflows without clear delegation, esthetician or LPN service expansion without state-specific review, questionable Botox or filler supply chains, GLP-1 or IV therapy add-ons, or aggressive advertising that makes medical promises without a matching clinical infrastructure.
Operator Impact
The operator impact is direct. Med spas may need to change who evaluates patients, who can inject, who can operate devices, who can delegate, how medical directors supervise, how product inventory is sourced, what appears on the website, what patients sign before treatment, and how complications are escalated.
Clinics that built growth around speed, cheap injections, thin oversight, and informal training can still grow, but only if they harden the operating model before regulators, plaintiff attorneys, bad outcomes, or competitors expose the gaps.
The Market Shift
The first phase of med spa growth was consumer demand. Patients wanted Botox, fillers, lasers, skin tightening, body contouring, weight-loss shots, IVs, NAD, hormone support, microneedling, and PRP in a convenient retail environment.
The second phase was operator arbitrage. Non-physician founders, injectors, nurses, marketers, and MSOs saw a fragmented cash-pay market with strong margins and repeat purchase behavior.
The third phase is now regulatory normalization. States are asking the obvious questions: who owns the medical decision, who evaluated the patient, who delegated the procedure, who sourced the drug, who trained the staff, who responds to complications, and who is accountable when the patient is harmed.
The Pattern Across States
The details vary by state, but the pattern is clear. Some states are creating registration frameworks. Some are tightening delegation and disclosure. Some are warning consumers after med spa investigations. Some are clarifying that there is no facility registration but medical delegation still applies. Some are requiring medical director standards. Some are using nursing-board guidance to define what RNs, LPNs, APRNs, estheticians, laser technicians, and other staff can or cannot do.
Operators should assume the state-by-state gray zone is shrinking.
The Medical Director Problem
The paper medical director model is the most obvious pressure point. A medical director who signs an agreement but does not train staff, review protocols, evaluate delegation, supervise procedures, review charts, oversee adverse-event workflows, or control medical decision-making is not a real medical director.
The more states formalize med spa rules, the more dangerous it becomes to treat the medical director as a compliance mascot. The question is no longer whether a clinic has a medical director. The question is whether the medical director can prove active oversight.
The Injector Scope Problem
Injector scope is not universal. A procedure that appears normal in one state may be restricted in another. RNs, LPNs, APRNs, PAs, physicians, dentists, estheticians, cosmetologists, and laser technicians are not interchangeable.
Some states allow nurses to perform certain aesthetic procedures only with individualized orders or prescriber evaluation. Others exclude dermal fillers or certain procedures from RN scope. Some allow expanded microneedling or dental injection authority through proposed bills. The safe operating model is not "our injector is experienced." The safe operating model is a documented procedure-by-procedure scope matrix.
The Product Sourcing Problem
The counterfeit Botox and illegal botulinum toxin warnings are not abstract. Product sourcing is part of the med spa risk stack.
Clinics need to know where neurotoxins, fillers, prescription weight-loss drugs, IV ingredients, numbing agents, and other products came from. They need invoice records, lot numbers, expiration dates, storage logs, authorized supplier documentation, and adverse-event workflows. A cheap vial from a questionable source can destroy the entire brand.
The Advertising Problem
Advertising is where the clinical model becomes visible. If a website says "safe," "medical-grade," "doctor supervised," "FDA-approved," "natural results," "weight loss shots," or "advanced aesthetic medicine," the clinic should be able to prove the operational reality behind those words.
The more regulated the service line, the more dangerous vague marketing becomes. Before-and-afters, testimonials, influencer clips, discounted injectable promos, and membership bundles should be reviewed against provider scope, sourcing, consent, and claims substantiation.
The Patient Experience Problem
The best med spa operators will turn compliance into trust. Patients do not need a legal lecture, but they do need to know who is treating them, what the provider is licensed to do, who supervises care, what product is being used, what risks exist, what to do if complications occur, and how follow-up works.
Patient disclosure is not just regulatory defense. It is a conversion advantage when written plainly.
Commander Action
- Build a procedure-by-procedure scope matrix for every service line and every state where the clinic operates.
- Audit the medical director model against protocols, training, chart review, adverse events, product oversight, delegation, and staff competency.
- Verify product sourcing and lot tracking for neurotoxins, fillers, GLP-1s, IV ingredients, numbing agents, PRP supplies, and other regulated products.
- Review patient assessment and order workflows for prescriber evaluation, individualized orders, history and physical, chart notes, and follow-up plans.
- Clean up staff role assignments so RNs, LPNs, APRNs, PAs, estheticians, dentists, laser technicians, and unlicensed staff are not crossing state-specific scope lines.
- Add patient-facing provider and supervision disclosures.
- Review website and ad claims around safety, medical supervision, FDA approval, product quality, results, and treatment efficacy.
- Create adverse-event escalation SOPs for vascular occlusion, infection, allergic reaction, burns, nerve injury, botulinum toxin adverse events, fainting, IV complications, and post-procedure complaints.
- Separate cosmetology services from medical services.
- Use plain-language safety and credential blocks to build trust without overwhelming the patient.
Service Menu
- Every service currently listed on the website
- Membership language that bundles medical services
Staff & Supervision
- Every person who performs or assists with each service
- Every supervising, delegating, ordering, or prescribing provider
- Medical director agreements and actual workflows
Patient Documents
- Patient intake forms, history forms, and consent forms
- Before-and-after gallery disclaimers
- Standing orders, individualized orders, and prescriber evaluation records
Product Sourcing
- Botox, neurotoxin, filler, and prescription-product supplier records
- Lot numbers, expiration dates, storage logs, and adverse-event logs
Device & Procedure Training
- Laser, IPL, RF, and microneedling training records
Advertising & Offers
- Landing pages, Google Ads, Meta ads, Instagram, TikTok, and email claims
- Discount, package, and offer language tied to medical services
New York warns consumers after med spa investigations
New York Department of State warned consumers after investigations into unauthorized med spa services, citing unlicensed activity and unsafe practices.
New York med spas should keep provider credentials, product sourcing, sanitation controls, supervision records, patient consent, and adverse-event response procedures audit-ready.
Texas confirms no med spa registration but physician delegation remains required
Texas Medical Board states there is currently no registration for med spa clinics, but nonsurgical medical procedures performed in Texas med spas must be delegated by a licensed physician.
Texas med spas should not confuse lack of facility registration with lack of medical regulation; physician delegation, protocols, supervision, credential disclosure, and recordkeeping remain core risk points.
Indiana med spa registration requirements begin January 1, 2027
Indiana SB 282 requires medical spa registration beginning January 1, 2027 and adds a state framework involving responsible practitioners, public database requirements, adverse-event reporting, advertising requirements, and compounding-related oversight.
Indiana med spas should prepare responsible-practitioner documentation, facility records, adverse-event reporting workflows, advertising review, compounding and medication-source review, and registration readiness before the 2027 deadline.
Florida med spa licensure bills died but prescription-drug oversight remains a watch item
Florida SB 1728 and companion HB 1429 proposed the Medical Spa Prescription Drug Oversight Act, but SB 1728 died in Health Policy on March 13, 2026.
Florida med spas should not treat the bill's death as a permanent safe harbor; prescription-drug sourcing, storage, adverse-event protocols, GLP-1 claims, pharmacy relationships, and medical oversight remain likely future pressure points.
Arizona bill would regulate med spas handling prescription medications
Arizona HB 4047 would create medical spa licensure and regulation requirements, including prescription medication acquisition, storage, security, inspection, and dispenser-related obligations.
Arizona med spas offering injectables, GLP-1s, hormones, IV therapy, or other prescription-based services should monitor the bill and review medication sourcing, storage, DSCSA-style documentation, responsible-person structure, and patient-facing claims.
Show all related signals (21)
Iowa medical spa oversight bill would create registration and practice requirements
Iowa HSB 591 would establish the Medical Spa Oversight Act and create a state framework for regulating medical spas that provide wellness services.
Iowa med spas and wellness clinics should monitor the bill and begin reviewing responsible-person assignment, registration readiness, prescription-medication handling, adverse-event workflows, and supervision protocols.
Massachusetts H5455 would regulate operation of medical spas
Massachusetts H5455, a new draft of H5087, would regulate the operation of medical spas and was referred to the House Committee on Ways and Means on May 26, 2026.
Massachusetts med spas should monitor licensing, ownership, clinic-licensure, procedure delegation, supervision, and patient-safety requirements as the bill advances.
Massachusetts advisory flags clinic licensure for practitioner-controlled med spas
Massachusetts guidance states that a medical spa providing medical services is subject to clinic licensure if it is not wholly owned and controlled by one or more practitioners.
Massachusetts operators should review ownership, control, clinic licensure, provider authority, and whether aesthetic or wellness services are being delivered through a structure that requires state clinic licensure.
Rhode Island Medical Spas Safety Act creates med spa supervision framework
Rhode Island enacted the Medical Spas Safety Act, creating statutory rules for cosmetic medical procedures, supervision, delegation, and medical spa safety.
Rhode Island med spas should review facility licensure, procedure delegation, provider qualifications, supervision documentation, adverse-event workflows, and cosmetic medical procedure protocols.
Washington publishes guidance for med spas and esthetic service businesses
Washington Department of Health guidance explains legal and practical considerations for businesses offering esthetic services, including injectables, lasers, body contouring, IV hydration, and telehealth-connected workflows.
Washington med spas should review ownership structure, medical director role, scope-of-practice boundaries, procedure delegation, telehealth use, licensed supervision, and whether staff are exceeding authorized practice.
Alaska medical spa services work group reviews high-risk med spa service lines
Alaska's Medical Spa Services Work Group is reviewing services including IV hydration, advanced esthetics, cosmetic injectables, prescription drugs, semaglutides, sildenafil, body contouring, and hyperbaric treatments.
Alaska med spas and wellness clinics should monitor work group output and keep provider scope, prescription workflows, medication sourcing, medical director oversight, and procedure documentation audit-ready.
Colorado HB25-1024 requires disclosures for delegated medical-aesthetic services
Colorado HB25-1024 requires certain disclosures when licensed professionals delegate medical-aesthetic services to individuals who are not licensed health care providers.
Colorado med spas should update onsite signage, websites, informed consent workflows, delegation records, patient disclosures, complaint information, and provider transparency when unlicensed staff perform delegated services.
Illinois IDFPR and IDPH issue med spa services memo
Illinois IDFPR and IDPH issued a memo addressing med spa services including Botox, weight-loss medication injections, dermal fillers, laser hair removal, platelet-rich plasma, and vitamins.
Illinois med spas should review physician delegation, APRN scope, PA delegation, RN/LPN role limits, infection prevention, IDPH facility considerations, drug sourcing, and procedure-specific documentation.
Iowa rule sets standards for med spa medical directors and delegated aesthetic services
Iowa rule 653—13.6 establishes standards of practice for medical directors at medical spas and for delegation and supervision of medical aesthetic services.
Iowa med spas should keep medical director credentials, advertising identification, weekly onsite supervision, chart review, staff competence documentation, laser technician training, and informed consent workflows audit-ready.
D.C. Board of Medicine policy classifies higher-risk aesthetic procedures as medicine
D.C. Board of Medicine Policy 15-02 classifies Level II and Level III aesthetic medical procedures as the practice of medicine and describes medical director, clinical director, and site director expectations.
D.C. med spas should review physician ownership, onsite presence expectations, director roles, credentialing, staffing coverage, procedure classification, medical records, and training before offering lasers, fillers, injections, or sclerotherapy.
Connecticut statute sets medical spa staffing, assessment, and disclosure requirements
Connecticut law defines medical spas and cosmetic medical procedures and requires medical spas to employ or contract with a physician, PA, or APRN for oversight and patient assessment.
Connecticut med spas should review supervising provider contracts, initial assessments, delegated procedure workflows, internet disclosures, advertising, written patient notices, and role transparency for physicians, PAs, APRNs, and RNs.
Maryland COMAR chapter governs cosmetic medical procedure delegation and devices
Maryland COMAR 10.32.09 governs delegation and assignment of cosmetic medical procedures and use of cosmetic medical devices, including lasers, IPL, RF, injections, dermabrasion, and fat-reduction procedures.
Maryland med spas should review physician qualifications, delegation eligibility, written protocols, training, non-physician responsibilities, device use, cosmetic injectables, and discipline risk before expanding service lines.
California Medical Board states med spas offering medical procedures must be physician-owned
California Medical Board guidance states medical spas are marketing vehicles for medical procedures and, if offering medical procedures, must be owned by physicians.
California med spa founders, MSOs, investors, injectors, and marketing partners should review ownership, physician control, management-service agreements, advertising, medical decision-making, and non-physician financial control points.
Georgia nursing position statement limits cosmetic/aesthetic procedures to ordered RN workflows
Georgia Board of Nursing position statement states RNs may perform cosmetic/aesthetic procedures under a valid individualized order and prescriber history and physical, while LPNs may not perform prescribed cosmetic/aesthetic procedures.
Georgia med spas should remove standing-order-only workflows for injectables, confirm individualized prescriber orders and history and physicals, document RN competency, and ensure LPNs are not injecting neuromodulators or fillers.
Arizona advisory opinion classifies medical aesthetic procedures across nurses, estheticians, and laser technologists
Arizona Board of Nursing advisory opinion addresses medical aesthetic procedures performed by nurses, cosmetologists, estheticians, and certified laser technologists under supervision and scope limits.
Arizona med spas should map every service to provider scope, supervision, order requirements, procedure risk level, laser technician status, RN/APRN duties, and cosmetology or radiation-control boundaries.
Nevada nursing board issues aesthetic practice decision for RN and LPN procedures
Nevada Board of Nursing approved a practice advisory decision addressing scope requirements and limitations for RNs and LPNs performing aesthetic and cosmetologic procedures.
Nevada med spas should review nurse training, ongoing competency, facility protocols, informed consent, documentation, APRN independence, procedure-specific limitations, and excluded services like certain liposuction or deep microneedling workflows.
North Carolina nursing position statement sets ordered-procedure requirements for cosmetic dermatology
North Carolina Board of Nursing position statement requires evaluation or assessment by a licensed prescriber and an order before licensed nurses perform cosmetic or aesthetic dermatological procedures.
North Carolina med spas should confirm prescriber evaluations, procedure orders, onsite supervision, nurse competency, emergency policies, laser guidance review, and business-ownership boundaries for RN-led aesthetic models.
North Carolina Medical Board treats laser hair and tattoo removal as laser surgery
North Carolina Medical Board position statement says laser hair and tattoo removal implicate laser surgery and require physician, PA, or NP examination before initial treatment and adequate supervision.
North Carolina laser clinics and med spas should review pre-treatment exams, laser protocols, supervising physician availability, topical anesthetic prescribing, staff training, device logs, and tattoo-removal workflows.
Louisiana nursing declaratory statement excludes dermal fillers from RN cosmetic scope
Louisiana State Board of Nursing declaratory statement addresses cosmetic aesthetic procedures by nurses and states dermal fillers, ablative laser, certain sclerotherapy, and hair transplant procedures are not within RN scope.
Louisiana med spas should review whether RNs are performing fillers, ablative laser, sclerotherapy beyond superficial veins, or other excluded procedures, and should verify prescriber involvement, competency, and facility policies.
Oklahoma medical spa guidelines clarify physician oversight and aesthetic procedure boundaries
Oklahoma medical and osteopathic board guidance provides med spa operating expectations around physician oversight, patient relationship, delegation, laser use, injectables, protocols, and documentation.
Oklahoma med spas should review whether medical directors are actively supervising, whether providers are operating inside scope, and whether protocols, consent, charting, emergency response, and delegation are sufficient.
South Carolina medical board policy addresses lasers and other aesthetic devices
South Carolina Board of Medical Examiners policy addresses lasers and other devices, including delegation of non-ablative treatments and RN laser hair removal under direct supervision.
South Carolina med spas and laser clinics should review direct supervision, RN laser hair removal criteria, PA/NP/physician delegation, device classification, training, adverse-event protocols, and procedure documentation.
Questions To Ask Counsel
- Does our ownership or MSO structure comply with this state's corporate practice and medical practice ownership rules?
- Which services on our menu are legally medical procedures in this state?
- Who may evaluate the patient before each procedure?
- Who may order, delegate, perform, and supervise each procedure?
- Can RNs, LPNs, estheticians, dentists, or laser technicians perform any part of the service line we are assigning to them?
- Are our standing orders sufficient, or do we need individualized patient-specific orders?
- What must our medical director do to satisfy real supervision requirements?
- Do our website claims create medical, product, or advertising risk?
- Are our neurotoxins, fillers, and prescription products sourced through lawful channels?
- What patient disclosures, signage, consent forms, or complaint information are required?
- Do our emergency protocols satisfy expected standard-of-care and board expectations?
- Are we using any device, product, or drug in a way that requires additional licensure, registration, or facility oversight?
Operator Takeaway
The durable med spa model is not anti-growth. It is disciplined growth. Clinics can still scale injectables, lasers, skin, IV, weight loss, and aesthetic medicine, but the operating model has to mature.
The safest growth path is to make the invisible medical infrastructure visible enough to build patient trust and strong enough to survive board scrutiny.
FDA alerts clinicians and consumers to counterfeit Botox found in multiple states
FDA alerted health care professionals and consumers that unsafe counterfeit versions of Botox had been found in multiple states and administered to consumers for cosmetic purposes.
Med spas offering neurotoxin injections should verify product sourcing, lot numbers, supplier authorization, storage records, adverse-event protocols, patient consent, and staff training before administering Botox or similar products.
FDA warns companies over illegal marketing of Botox and related products
FDA issued warning letters to website operators illegally marketing unapproved and misbranded botulinum toxin products, including Botox-like products associated with botulism symptoms.
Med spas should audit whether any neurotoxin products are sourced from unauthorized online sellers, foreign marketplaces, or third-party distributors that cannot document FDA-approved product status and legitimate supply chain controls.
Colorado SB26-130 would treat certain med spa failures as deceptive trade practices
Colorado SB26-130 would make certain conduct by medical spas involving prescription drugs an unfair or deceptive trade practice under the Colorado Consumer Protection Act.
Colorado med spas should monitor the bill and review prescription-drug acquisition, storage, preparation, administration, provider scope, delegation, compounding, sterile drug products, and patient-facing claims.
Colorado Rule 800 governs delegation and supervision of medical-aesthetic services
Colorado's medical delegation rule governs physician delegation and supervision of medical services, including medical-aesthetic services performed by non-licensed or non-physician personnel.
Colorado med spas should maintain written delegation agreements, procedure protocols, emergency protocols, chart review, staff qualification reassessments, and documented supervision for delegated aesthetic services.
Connecticut HB 5399 would expand dentistry-related cosmetic injection authority
Connecticut HB 5399, a dentistry bill, includes provisions that would permit licensed dentists to administer cosmetic injections such as botulinum toxin and dermal fillers.
Connecticut med spas, dental spas, and aesthetic clinics should monitor the bill because dental injector expansion could affect local competition, scope boundaries, referral models, and consent/disclosure workflows.
Show all watch items (16)
Texas SB 2696 proposed advanced cosmetic procedure license after med spa safety concerns
Texas SB 2696 proposed an advanced cosmetic procedure license for cosmetic injections, dermis-damaging procedures, and certain cosmetic medical devices, but did not complete passage in the 2025 regular session.
Texas med spas should treat the bill as a strong policy signal around injector competency, written physician protocols, client disclosures, training, examination, scope boundaries, and future licensing pressure.
Texas TDLR guidance separates cosmetology services from med spa medical treatments
Texas TDLR guidance explains that med spas may include cosmetology services, but Botox, filler injections, body contouring, laser-assisted skin treatments, and medical-grade facial treatments fall under medical treatment rules.
Texas med spas should separate cosmetology scope from physician-delegated medical procedures and make sure estheticians, cosmetology operators, laser staff, and medical staff are not crossing license boundaries.
Washington nursing advisory opinion addresses cosmetic and aesthetic dermatologic procedures
Washington Nursing Care Quality Assurance Commission advisory opinion addresses RN and LPN performance of cosmetic and aesthetic dermatologic procedures under authorized practitioner direction.
Washington med spas should align nurse workflows with authorized practitioner direction, written regimens, scope decision trees, laser and energy-device rules, standing orders, and procedure-specific competency records.
North Dakota nursing FAQ addresses RN and APRN practice in aesthetic settings
North Dakota Board of Nursing FAQ addresses RN and APRN practice in aesthetic settings, including aesthetic injections under a medically prescribed treatment plan and documented prescriber assessment.
North Dakota med spas should review prescriber assessment, treatment plans, RN training, injectable competency, FDA-approved aesthetic agents, documentation, and physician/APRN involvement before offering injectables.
Oklahoma nursing guidelines address cosmetic and aesthetic dermatological procedures
Oklahoma Board of Nursing guidance addresses cosmetic and aesthetic dermatological procedures and references med spa and osteopathic medical spa policy expectations.
Oklahoma med spas should align nurse roles, prescriber orders, competency validation, emergency policies, aesthetic procedure protocols, and board-specific scope limits before assigning injectables, lasers, or advanced procedures.
Montana Board of Nursing FAQ flags scope analysis for med spa cosmetic procedures
Montana Board of Nursing med spa FAQ states health care providers must determine whether specific cosmetic procedures are within their scope of practice.
Montana med spas should document procedure-by-procedure scope analysis, provider competency, prescriber involvement, delegation, policies, patient consent, and when services require medical versus cosmetology governance.
Oregon Board of Nursing FAQ addresses RN participation in cosmetic procedures
Oregon Board of Nursing FAQ states RN participation in cosmetic procedures depends on individual scope of practice analysis under Oregon nursing standards.
Oregon med spas should document RN scope analysis, orders, competency, policies, delegation, supervision, adverse-event response, and whether cosmetic procedures are being assigned without sufficient nursing-basis review.
Kentucky nursing advisory statement addresses cosmetic and dermatologic procedures
Kentucky Board of Nursing advisory guidance addresses cosmetic and dermatological procedures performed by nurses in aesthetic practice settings.
Kentucky med spas should review nurse competency, prescriber orders, delegation, scope boundaries, cosmetic procedure protocols, emergency procedures, and medical director oversight.
New York microneedling scope bill remains active for estheticians and cosmetologists
New York A3084 would allow licensed estheticians and licensed cosmetologists to perform microneedling after completing required training.
New York med spas and aesthetic clinics should monitor whether microneedling scope expands beyond current medical-provider workflows and update training, delegation, consent, and supervision policies if the bill advances.
Texas elective IV hydration law tightens physician-order and licensed-administration rules
Texas Medical Board guidance states elective IV hydration must be ordered by a physician or by a PA/APRN acting under adequate physician supervision, and administration must be performed by a licensed professional nurse or higher-level licensee.
Texas IV lounges, wellness clinics, med spas, and mobile IV operators should review ordering authority, delegation agreements, staffing licenses, emergency protocols, standing orders, and advertising around elective IV therapy.
Wisconsin boards issue joint advisory opinion on IV hydration therapy businesses
Wisconsin issued joint board guidance stating that IV hydration therapy businesses implicate medical, nursing, pharmacy, cosmetology, physician assistant, and controlled-substance standards.
Wisconsin IV clinics, med spas, mobile hydration operators, and wellness clinics should review assessment authority, prescribing, compounding, USP <797>, drug sourcing, informed consent, emergency policies, and provider scope boundaries.
North Carolina nursing position statement governs IV hydration clinic workflows
North Carolina Board of Nursing guidance addresses RN, LPN, and APRN responsibilities for IV hydration, nutrient therapies, and medications in wellness and mobile hydration settings.
North Carolina IV hydration businesses should confirm valid individualized orders, client history and physical workflows, prescriber authority, nurse competency, emergency procedures, and on-site policies before scaling walk-in or mobile IV offers.
Georgia Board of Nursing issues IV hydration position statement
Georgia Board of Nursing issued a position statement on IV hydration, nutrient therapies, and medication administration in non-traditional wellness settings.
Georgia IV hydration operators should confirm individualized prescriber orders, completed history and physicals, nurse scope boundaries, standing-order limitations, emergency procedures, and compliance with nursing, pharmacy, and medical board rules.
Kansas boards issue joint statement on retail IV therapy
Kansas Board of Healing Arts and Board of Pharmacy issued a joint statement addressing patient safety and regulatory compliance concerns in retail IV therapy clinics.
Kansas IV therapy clinics, med spas, and wellness clinics should review prescriber involvement, pharmacy sourcing, compounding, administration authority, patient assessment, emergency procedures, and supervision workflows.
California restricts PE and hedge fund interference with physician and dental judgment
California SB 351 prohibits private equity groups and hedge funds involved with physician or dental practices from interfering with professional judgment or exercising control over specified clinical and business functions.
California MSO, investor-backed, and rollup models should review control rights, employment decisions, clinical protocols, coding and billing authority, record ownership, equipment approvals, and restrictive covenants.
California AB 1415 expands OHCA transaction oversight to MSOs and investor entities
California AB 1415 became effective January 1, 2026 and expands Office of Health Care Affordability oversight for certain health care transactions involving private equity groups, hedge funds, MSOs, and related noticing entities.
California MSOs, med spa platforms, DPC groups, concierge groups, telehealth groups, and rollups should review whether transactions, ownership changes, or management arrangements trigger OHCA notice obligations.
Source Ledger
- Source: New York Department of State Issues Warning to Consumers After Investigations into Med Spa Service ProvidersNew York Department of State Issues Warning to Consumers After Investigations into Med Spa Service Providers - Signal date: January 8, 2026
- Source: How do I register as a Med Spa? - Texas Medical BoardHow do I register as a Med Spa? - Texas Medical Board
- Source: Indiana SB0282 | 2026 | Regular SessionIndiana SB0282 | 2026 | Regular Session - Signal deadline: January 1, 2027
- Source: SB 1728SB 1728: Licensure of Medical Spas - The Florida Senate
- Source: AZ HB4047 | 2026 | Fifty-seventh Legislature 2nd RegularAZ HB4047 | 2026 | Fifty-seventh Legislature 2nd Regular
- Source: HSB 591 - Iowa LegislatureHSB 591 - Iowa Legislature
- Source: Bill H.5455 - Massachusetts LegislatureBill H.5455 - Massachusetts Legislature
- Source: Medical Spa Services AdvisoryMedical Spa Services Advisory
- Source: RI S0976 | 2025 | Regular SessionRI S0976 | 2025 | Regular Session - Signal deadline: July 1, 2026
- Source: Information and Guidance for Operating a Med Spa or Business Offering Esthetic Services to the PublicInformation and Guidance for Operating a Med Spa or Business Offering Esthetic Services to the Public
- Source: Medical Spa Services Work GroupMedical Spa Services Work Group
- Source: Medical-Aesthetic Services Delegation DisclosuresMedical-Aesthetic Services Delegation Disclosures - Signal deadline: August 6, 2025
- Source: IDFPR, IDPH Issue Memo Regarding Medical Spa ServicesIDFPR, IDPH Issue Memo Regarding Medical Spa Services - Signal date: October 30, 2025
- Source: Iowa Medical Spa Rule 653—13.6Iowa Medical Spa Rule 653—13.6 - Signal date: April 16, 2025
- Source: D.C. Board of Medicine Policy on the Practice of Aesthetic MedicineD.C. Board of Medicine Policy on the Practice of Aesthetic Medicine - Signal date: November 13, 2014
- Source: Connecticut General Statutes Chapter 368llConnecticut General Statutes Chapter 368ll - Signal date: October 1, 2014
- Source: COMAR 10.32.09 Delegation and Assignment of Performance of Cosmetic Medical Procedures and Use of Cosmetic Medical DevicesCOMAR 10.32.09 Delegation and Assignment of Performance of Cosmetic Medical Procedures and Use of Cosmetic Medical Devices
- Source: Medical Spas - Medical Board of CaliforniaMedical Spas - Medical Board of California
- Source: Position StatementPosition Statement: Cosmetic/Aesthetic Procedures - Signal date: March 1, 2024
- Source: Medical Aesthetic Procedures Performed by Licensed Nurses, Licensed Cosmetologist, Licensed Aestheticians and Certified Laser TechnologistsMedical Aesthetic Procedures Performed by Licensed Nurses, Licensed Cosmetologist, Licensed Aestheticians and Certified Laser Technologists - Signal date: March 1, 2019
- Source: Scope of Practice Requirements and Limitations for RNs and LPNs Performing Aesthetic/Cosmetologic ProceduresScope of Practice Requirements and Limitations for RNs and LPNs Performing Aesthetic/Cosmetologic Procedures - Signal date: January 17, 2025
- Source: Cosmetic/Aesthetic Dermatological ProceduresCosmetic/Aesthetic Dermatological Procedures
- Source: 5.1.25.1.2: Laser Surgery
- Source: Declaratory Statement - Cosmetic Aesthetic Procedures by RNs and APRNsDeclaratory Statement - Cosmetic Aesthetic Procedures by RNs and APRNs - Signal date: March 2, 2011
- Source: Guidelines for Oklahoma Medical Spas & Aesthetic ProceduresGuidelines for Oklahoma Medical Spas & Aesthetic Procedures - Signal date: January 18, 2024
- Source: Lasers and Other Devices - South Carolina LLRLasers and Other Devices - South Carolina LLR
- Source: Counterfeit Version of Botox Found in Multiple StatesCounterfeit Version of Botox Found in Multiple States - Signal date: April 16, 2024
- Source: FDA Warns Companies Over Illegal Marketing of Botox and Related ProductsFDA Warns Companies Over Illegal Marketing of Botox and Related Products - Signal date: November 5, 2025
- Source: SB26-130 Medical Spas Deceptive Trade PracticesSB26-130 Medical Spas Deceptive Trade Practices
- Source: 3 CCR 713-1.17 - Delegation and Supervision of Medical Services3 CCR 713-1.17 - Delegation and Supervision of Medical Services
- Source: CT HB05399 | 2026 | General AssemblyCT HB05399 | 2026 | General Assembly
- Source: TX SB2696 | 2025-2026 | 89th LegislatureTX SB2696 | 2025-2026 | 89th Legislature
- Source: Medical Spas - Texas Department of Licensing and RegulationMedical Spas - Texas Department of Licensing and Regulation
- Source: Advisory OpinionAdvisory Opinion: Cosmetic/Aesthetic Dermatologic Procedures - Signal date: May 14, 2021
- Source: Nursing Practice FAQ - North Dakota Board of NursingNursing Practice FAQ - North Dakota Board of Nursing - Signal date: February 13, 2025
- Source: Cosmetic/Aesthetic Dermatological Procedures GuidelinesCosmetic/Aesthetic Dermatological Procedures Guidelines
- Source: Montana Board of Nursing FAQs - Med SpaMontana Board of Nursing FAQs - Med Spa - Signal date: September 22, 2020
- Source: RN Frequently Asked Questions - Oregon State Board of NursingRN Frequently Asked Questions - Oregon State Board of Nursing
- Source: AOS #35 Cosmetic and Dermatological Procedures by NursesAOS #35 Cosmetic and Dermatological Procedures by Nurses
- Source: NY State Assembly Bill 2025-A3084NY State Assembly Bill 2025-A3084
- Source: Who Can Do IV Hydration? - Texas Medical BoardWho Can Do IV Hydration? - Texas Medical Board - Signal date: September 1, 2025
- Source: Joint Advisory Opinion Regarding IV Hydration Therapy BusinessJoint Advisory Opinion Regarding IV Hydration Therapy Business - Signal date: October 22, 2025
- Source: Administration of Intravenous Fluids, Nutrient Therapies, and Medications for Hydration, Health, and WellnessAdministration of Intravenous Fluids, Nutrient Therapies, and Medications for Hydration, Health, and Wellness
- Source: IV Hydration Position StatementIV Hydration Position Statement - Signal date: April 1, 2024
- Source: Kansas State Board of Healing Arts and Board of Pharmacy Issue Joint Statement Regarding Intravenous TherapyKansas State Board of Healing Arts and Board of Pharmacy Issue Joint Statement Regarding Intravenous Therapy - Signal date: February 25, 2026
- Source: Bill Text - SB-351 Health FacilitiesBill Text - SB-351 Health Facilities - Signal date: January 1, 2026
- Source: AB 1415 Frequently Asked Questions (FAQ)AB 1415 Frequently Asked Questions (FAQ) - Signal date: January 1, 2026
Request a Command Matrix audit
Find the weak links across acquisition, follow-up, offers, systems, and execution.
Join Clinic Commanders
Step into the private command room for clinic owners who want sharper operating visibility.